Oct 162017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, NY – AzurRx BioPharma, Inc. (NASDAQ:AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases today announced the appointment of Dr.=> Read more

AzurRx BioPharma appointed Dr Vern Schramm to the Board of Directors

From:: AzurRx BioPharma appointed Dr Vern Schramm to the Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: